Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Philipp Badorrek
Observed names:
Badorrek, P.,
Badorrek, Philipp,
P Badorrek,
P. Badorrek,
P., Badorrek,
Philipp Badorek
show all 6
Institution:
Fraunhofer Institute for Toxicology and Experimental Medicine
Observed institutions:
University of Ferrara,
Medizinische Hochschule Hannover,
Fraunhofer Institute for Toxicology and Experimental Medicine,
German Center for Lung Research,
Fraunhofer-Gesellschaft
ORCID:
0000-0003-2490-0583
Observed ORCID:
0000-0003-2490-0583
OpenAlex ID:
A5080825806
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
2019
·
Dirkje S Postma
, Chris Brightling
, et al.
·
The Lancet Respiratory Medicine
·
454
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
2016
·
Diane Lefaudeux
, Bertrand De Meulder
, et al.
·
Journal of Allergy and Clinical Immunology
·
323
PDF
Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber
2015
·
Thomas Werfel
, Annice Heratizadeh
, et al.
·
Journal of Allergy and Clinical Immunology
·
186
IL-17–high asthma with features of a psoriasis immunophenotype
2019
·
Jörgen Östling
, Marleen van Geest
, et al.
·
Journal of Allergy and Clinical Immunology
·
135
PDF
Stratification of asthma phenotypes by airway proteomic signatures
2019
·
James P.R. Schofield
, Dominic Burg
, et al.
·
Journal of Allergy and Clinical Immunology
·
94
PDF
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study
2022
·
Tessa M Kole
, Elise Vanden Berghe
, et al.
·
The Lancet Respiratory Medicine
·
87
PDF
Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis
2003
·
N. Krug
, H. Loedding
, et al.
·
Clinical & Experimental Allergy
·
77
PDF
Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis
2013
·
Norbert Krug
, Abhya Gupta
, et al.
·
Journal of Allergy and Clinical Immunology
·
57
PDF
Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure
2017
·
Philipp Badorrek
, Meike Müller
, et al.
·
Annals of Allergy Asthma & Immunology
·
50
PDF
The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis
2020
·
Ivo Nnane
, Bart Frederick
, et al.
·
British Journal of Clinical Pharmacology
·
44
Lung pharmacokinetics of inhaled and systemic drugs: A clinical evaluation
2021
·
Muhammad Waqas Sadiq
, Olaf Holz
, et al.
·
British Journal of Pharmacology
·
40
PDF
Anti-allergic drug testing in an environmental challenge chamber is suitable both in and out of the relevant pollen season
2011
·
Philipp Badorrek
, Melanie Dick
, et al.
·
Annals of Allergy Asthma & Immunology
·
33
A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis
2009
·
P. Badorrek
, M. Dick
, et al.
·
International Journal of Clinical Pharmacology and Therapeutics
·
31
Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis
2015
·
Philipp Badorrek
, Jens M. Hohlfeld
, et al.
·
Annals of Allergy Asthma & Immunology
·
28
PDF
Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber
2016
·
K. Lueer
, H. Biller
, et al.
·
Allergy
·
23
Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge
2020
·
Sarah Mole
, Anya Harry
, et al.
·
Pulmonary Pharmacology & Therapeutics
·
21
PDF
Pollen starch granules in bronchial inflammation
2012
·
Philipp Badorrek
, Melanie Dick
, et al.
·
Annals of Allergy Asthma & Immunology
·
17
Effects of Anti-IL-13 (Novartis QAX576) on Inflammatory Responses Following Nasal Allergen Challenge (NAC).
2009
·
HH Kariyawasam
, GC Nicholson
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
16
Novel cathepsin C inhibitor, BI 1291583, intended for treatment of bronchiectasis: Phase I characterization in healthy volunteers
2024
·
Philipp Badorrek
, Claudia Diefenbach
, et al.
·
Clinical and Translational Science
·
15
PDF
The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583
2024
·
James D. Chalmers
, Philipp Badorrek
, et al.
·
ERJ Open Research
·
13
PDF
Efficacy and Safety of a Drug-Free, Barrier-Forming Nasal Spray for Allergic Rhinitis: Randomized, Open-Label, Crossover Noninferiority Trial
2022
·
Julian Nehrig
, Nicole Grosse
, et al.
·
International Archives of Allergy and Immunology
·
13
The Effect of a Thixotropic Nasal Gel on Nasal Symptoms and Inflammatory Biomarkers in Seasonal Allergic Rhinitis
2020
·
Nadja Struß
, Philipp Badorrek
, et al.
·
International Archives of Allergy and Immunology
·
11
Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies
2018
·
Alan D. Rogol
, Natalia Tkachenko
, et al.
·
Canadian Urological Association Journal
·
11
PDF
Phase I Characterization of the Novel Cathepsin C Inhibitor BI 1291583
2022
·
P. Badorrek
, C. Diefenbach
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
10
Effects of Recombinant Human Angiotensin-Converting Enzyme 2 on Response to Acute Hypoxia and Exercise: A Randomised, Placebo-Controlled Study
2021
·
David A. Hall
, Kate Hanrott
, et al.
·
Pulmonary Therapy
·
10
PDF
Show more works
View as search
Works count:
69
Citation count:
1,859
H-index:
17
I10-index:
25
Year
Topic
Type